Status:
COMPLETED
Efficacy of Concerta in Treating ADHD in Mothers of Children With ADHD
Lead Sponsor:
University of Maryland, College Park
Collaborating Sponsors:
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
Children's National Research Institute
Conditions:
Adult ADHD
Eligibility:
FEMALE
Phase:
PHASE4
Brief Summary
This study involves a 7 week dose-response trial of Concerta™ methylphenidate for mothers of children with ADHD who have ADHD themselves. The aim of this study is to assess the efficacy of Concerta™ i...
Detailed Description
There is evidence to suggest that ADHD persists in approximately 50-65% of individuals diagnosed with the disorder during childhood. Due to the familial nature and presumed genetic etiology of this di...
Eligibility Criteria
Inclusion
- Mother:
- Have ADHD or problems paying attention and concentration themselves
- Have a child 6-12 years old with ADHD or possible ADHD
- Be the child's biological mother
Exclusion
- Any CURRENT Axis I disorder (including major depression, psychosis, and substance use disorders) but with the exception of minor depressive or anxiety disorders
- Use of Anti-depressant medication
- Mothers with severe tics or Tourette's syndrome, a history of seizures or abnormal EEGs, high blood pressure, or narrowing or blockage of the GI tract
- Any women pregnant or brest-feeding
Key Trial Info
Start Date :
December 1 2004
Trial Type :
INTERVENTIONAL
End Date :
December 1 2006
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00318981
Start Date
December 1 2004
End Date
December 1 2006
Last Update
December 27 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's National Medical Center Regional Outpatient Center
Fairfax, Virginia, United States, 22031